Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models.
暂无分享,去创建一个
Y. Morishita | I. Takeyoshi | Y. Kawashima | S. Ohwada | M. Kasahara | Y. Sunose | N. Tomizawa | T. Ogawa | K. Matsumoto | H. Tsutsumi | S. Kawate | S. Iwazaki | M. Aiba
[1] K. Nishigaki,et al. Effects of low-dose Beraprost sodium, a stable prostaglandin I2 analogue, on reperfusion injury to rabbit lungs. , 1998, American Journal of Respiratory and Critical Care Medicine.
[2] M. Yanagisawa,et al. Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts. , 1998, American journal of respiratory and critical care medicine.
[3] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[4] R. Turnage,et al. Pulmonary thromboxane release following intestinal reperfusion. , 1995, Journal of Surgical Research.
[5] L. Rubin,et al. Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs. , 1989, Journal of applied physiology.
[6] P. Ward,et al. Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement. , 1988, Laboratory investigation; a journal of technical methods and pathology.